To identify further potential and possibly more efficient strategies for TAM inhibition in this study, the role of the chemokine receptor CCR4 on TAM and its ligands CCL17 and CCL22 is of interest—especially in pancreatic cancer. This evidence concerns the gene CCR4 and pancreatic neoplasm.